Apollon Wealth Management, LLC Novavax Inc Transaction History

Apollon Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $168,334 - $272,680	-1,251 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $18,669 - $28,410	-105 Reduced 7.74%	1,251 $259,000
Q2 2021 Aug 12, 2021	BUY	$121.0 - $257.67 $2,662 - $5,668	22 Added 1.65%	1,356 $288,000
Q1 2021 May 17, 2021	BUY	$112.98 - $319.93 $150,715 - $426,786	1,334 New	1,334 $242,000
Q3 2020 Nov 03, 2020	SELL	$79.44 - $178.51 $2,780 - $6,247	-35 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $485 - $2,926	35 New	35 $3,000

284

83.2M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $1.04B
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Apollon Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Apollon Wealth Management, LLC with notifications on news.